Autopsy report · NCT01532076

Effectiveness of Adipose Tissue Derived Mesenchymal Stem Cells as Osteogenic Component in Composite Grafts

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Slow recruitment”

The sponsor’s own words in the registry.

Life of this trial

Registered 5 months before it started.
Ran for about 2 years 3 months before it stopped.
8 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: University Hospital, Basel, Switzerland
Sponsor type: University, hospital or other
Conditions: Osteoporotic Fractures
Interventions: Cellularized composite graft augmentation; Acellular composite graft augmentation
Participants: 8
Sites: 1
Countries: Switzerland

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.